Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient von Ribeiro, Maurício Fernando Silva Almeida, Knebel, Franciele Hinterholz, Bettoni, Fabiana, Saddi, Rodrigo, Sacardo, Karina Perez, Canedo, Felipe Sales Nogueira Amorim, Alessi, João Victor Machado, Shimada, Andrea Kazumi, Marin, José Flávio Gomes, Camargo, Anamaria Aranha, Katz, Artur

Volltext

Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer von Khan, Shah Zeb, Arecco, Luca, Villarreal-Garza, Cynthia, Sirohi, Bhawna, Ponde, Noam F, Habeeb, Baker, Brandão, Mariana, Azim, Jr, Hatem A, Chowdhury, Arman Reza, Bozovic-Spasojevic, Ivana, Kovalenko, Iryna, Odhiambo, Andrew, Seid, Fahmi Usman, Mutombo, Alex Baleka, Petracci, Fernando, Vidra, Radu, Altuna, Sara C, Petrova, Mila, Kourie, Hampig Raphael, Ozturk, Mehmet Akif, Razeti, Maria Grazia, Lengyel, Csongor György, Talibova, Narmin, Mariamidze, Elene, Sacardo, Karina Perez, Duma, Narjust, Gyawali, Bishal, Trapani, Dario, Tagliamento, Marco, Lambertini, Matteo

Volltext

Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil von Queiroz, Marcello Moro, Sacardo, Karina Perez, Ribeiro, Mauricio Fernando, Gadotti, Luiza Lara, Saddi, Rodrigo, Oliveira, Leandro Jonata de Carvalho, Linck, Rudinei Diogo Marques, Cruz, Marcelo Rocha de Souza, Barroso-Sousa, Romualdo, Sahade, Marina, Correa, Tatiana Strava, Mano, Max Senna, Suzuki, Daniele Assad, Shimada, Andrea Kazumi, Katz, Artur

Volltext

Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma von Ribeiro, Maurício Fernando Silva Almeida, Gadotti, Luiza Lara, Sacardo, Karina Perez, Lopes, Carlos Diego Holanda, Saddi, Rodrigo, Alessi, João Victor Machado, de Macedo, Mariana Petaccia, do Nascimento, Ellen Caroline Toledo, Testagrossa, Leonardo de Abreu, Katz, Artur

Volltext

Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series von Ribeiro, Maurício Fernando Silva Almeida, Alessi, João Victor Machado, Oliveira, Leandro Jonata Carvalho, Gongora, Aline Bobato Lara, Sacardo, Karina Perez, Zucchetti, Bruna Migliavacca, Shimada, Andrea Kazumi, de Galiza Barbosa, Felipe, Feher, Olavo, Katz, Artur

Volltext

Successful Drug Rechallenge Following Severe Acute Alectinib-induced Interstitial Lung Disease in a Patient With Advanced ALK-rearranged Lung Adenocarcinoma von Gadotti, Luiza Lara, Nogueira Amorim Canedo, Felipe Sales, Ribeiro, Maurício Fernando Silva Almeida, Sacardo, Karina Perez, Saddi, Rodrigo, Machado Alessi, João Victor, de Abreu Testagrossa, Leonardo, Katz, Artur

Volltext

Unique fusion is associated with marked response to crizotinib in lung adenocarcinoma von Maurício Fernando Silva Almeida Ribeiro, Luiza Lara Gadotti, Karina Perez Sacardo, Carlos Diego Holanda Lopes, Rodrigo Saddi, João Victor Machado Alessi, Mariana Petaccia de Macedo, Ellen Caroline Toledo do Nascimento, Leonardo de Abreu Testagrossa, Artur Katz

Volltext

Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient von Ribeiro, Maurício Fernando Silva Almeida, Knebel, Franciele Hinterholz, Bettoni, Fabiana, Saddi, Rodrigo, Sacardo, Karina Perez, Canedo, Felipe Sales Nogueira Amorim, Alessi, João Victor Machado, Shimada, Andrea Kazumi, Marin, José Flávio Gomes, Camargo, Anamaria Aranha, Katz, Artur

Volltext

Successful Drug Rechallenge Following Severe Acute Alectinib-induced Interstitial Lung Disease in a Patient With Advanced ALK-rearranged Lung Adenocarcinoma von Gadotti, Luiza Lara, Nogueira Amorim Canedo, Felipe Sales, Ribeiro, Maurício Fernando Silva Almeida, Sacardo, Karina Perez, Saddi, Rodrigo, Machado Alessi, João Victor, de Abreu Testagrossa, Leonardo, Katz, Artur

Volltext

Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma von Ribeiro, Maurício Fernando Silva Almeida, Gadotti, Luiza Lara, Sacardo, Karina Perez, Lopes, Carlos Diego Holanda, Saddi, Rodrigo, Alessi, João Victor Machado, de Macedo, Mariana Petaccia, do Nascimento, Ellen Caroline Toledo, Testagrossa, Leonardo de Abreu, Katz, Artur

Volltext